PET for dementia drug test.

[Drug development for overcoming dementia in Japan].

Brain fluorodeoxyglucose (FDG) PET in dementia.

Development of the Cognitive Test for Severe Dementia.

Use of the Dementia Rating Scale as a test for neuropsychological dysfunction in HIV-positive i.v. drug abusers.

Fragrance mix I: TRUE Test(®) versus pet.-based patch test.

Rapid test for drug resistance in leprosy.

Drug Therapy for Behavioral and Psychological Symptoms of Dementia.

PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.

Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.

An autoradiographic evaluation of AV-1451 Tau PET in dementia.

Posterior cortical dementia with alexia: neurobehavioural, MRI, and PET findings.

Diagnostic impact of [18F]flutemetamol PET in early-onset dementia.

Brain FDG PET and the diagnosis of dementia.

Automated identification of dementia using FDG-PET imaging.

Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.

Three-question dementia screening. Development of the Salzburg Dementia Test Prediction (SDTP).

Aseptic simulation test for cytotoxic drug production in isolators.

The clock drawing test, mortality, incident cardiovascular events and dementia.

A Brief Dementia Test with Subjective and Objective Measures.

CT for ¹⁸F-FDG Brain Imaging in Patients Examined for Suspected Dementia.

Using the affective bias test to predict drug-induced negative affect: implications for drug safety.

Italian Multicentre Study on Dementia (SMID): a neuropsychological test battery for assessing Alzheimer's disease.

Effect of education on the mini-mental state examination as a screening test for dementia.

Is it time to replace the Abbreviated Mental Test Score as a screening tool for dementia?

Suggest Documents

[Drug development for overcoming dementia in Japan].

Brain fluorodeoxyglucose (FDG) PET in dementia.

Development of the Cognitive Test for Severe Dementia.

Use of the Dementia Rating Scale as a test for neuropsychological dysfunction in HIV-positive i.v. drug abusers.

Fragrance mix I: TRUE Test(®) versus pet.-based patch test.

Rapid test for drug resistance in leprosy.

Drug Therapy for Behavioral and Psychological Symptoms of Dementia.

PET Radioligands Reveal the Basis of Dementia in Parkinson's Disease and Dementia with Lewy Bodies.

Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.

An autoradiographic evaluation of AV-1451 Tau PET in dementia.

Posterior cortical dementia with alexia: neurobehavioural, MRI, and PET findings.

Diagnostic impact of [18F]flutemetamol PET in early-onset dementia.

Brain FDG PET and the diagnosis of dementia.

Automated identification of dementia using FDG-PET imaging.

Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting.

Three-question dementia screening. Development of the Salzburg Dementia Test Prediction (SDTP).

Aseptic simulation test for cytotoxic drug production in isolators.

The clock drawing test, mortality, incident cardiovascular events and dementia.

A Brief Dementia Test with Subjective and Objective Measures.

CT for ¹⁸F-FDG Brain Imaging in Patients Examined for Suspected Dementia.

Using the affective bias test to predict drug-induced negative affect: implications for drug safety.

Italian Multicentre Study on Dementia (SMID): a neuropsychological test battery for assessing Alzheimer's disease.

Effect of education on the mini-mental state examination as a screening test for dementia.

Is it time to replace the Abbreviated Mental Test Score as a screening tool for dementia?

PET for dementia drug test.

Recommend Documents

Follow Us